Regeneron Pharmaceuticals vs. Amgen - APL_572929/2023

The case APL_572929/2023 was filed by the plaintiff Regeneron Pharmaceuticals Inc., Sanofi-Aventis Deutschland Gmbh against the defendant Amgen Inc. on 13 Sep, 2023. The case decision was made on Oct 13, 2023.

13 Sep, 2023
Case Filed
Oct 13, 2023
Decision

Case Details

    Case Number:

    APL_572929/2023

    Filing Date:

    13 Sep, 2023

    Proceeding Type:

    Appeal

    Action/Application:

    Appeal Rop220.2

    Plaintiffs:

    • Regeneron Pharmaceuticals Inc.
    • Sanofi-Aventis Deutschland Gmbh
    • Sanofi-Aventis Groupe S.A.
    • Sanofi Winthrop Industrie S.A.

    Plaintiff Representative:

    • Niels Hoelder

    Defendants:

    • Amgen Inc.

    Defendant Representative:

    • Johannes Heselberger

    Judges:

    • Ingeborg Simonsson
    • Patricia Rombach
    • Rian Kalden

Case Decision

    Decision Date:

    Oct 13, 2023

    Decision Document:

    View document

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34318/2025Aug 5, 2025Regeneron Pharmaceuticals -
APP_33251/2025Jul 21, 2025Regeneron Pharmaceuticals -
APL_32715/2025Jul 14, 2025Regeneron PharmaceuticalsAmgen, Amgen Europe

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -